Supplementary Data S2 from SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance حسب Kristen Jensen-Pergakes (15090247)

Supplementary Data S3 from SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance حسب Kristen Jensen-Pergakes (15090247)

Image1_Scorpion Venom Heat–Resistant Synthesized Peptide Increases Stress Resistance and Extends the Lifespan of Caenorhabditis elegans via the Insulin/IGF-1-Like Signal Pathway.ti... حسب Ying-Zi Wang (11517934)

"…Based on the amino acid sequence of these peptides, scorpion venom heat–resistant synthesized peptide (SVHRSP) was prepared using polypeptide synthesis technology. …"

Image_1_Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma.tif حسب Emily C. Matchett (17037846)

"…Introduction<p>Over the last decade, there have been many advancements in the therapeutic treatment of multiple myeloma (MM), including the use of natural killer (NK) cells. …"

Image_2_Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma.tif حسب Emily C. Matchett (17037846)

"…Introduction<p>Over the last decade, there have been many advancements in the therapeutic treatment of multiple myeloma (MM), including the use of natural killer (NK) cells. …"

Supplementary Figures 1-8 from Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency حسب Wan-Ching Yen (11520727)

Table S6 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents حسب Filippo Spriano (15002903)

Table S5 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents حسب Filippo Spriano (15002903)

Table S1 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents حسب Filippo Spriano (15002903)

Table S2 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents حسب Filippo Spriano (15002903)

Table S3 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents حسب Filippo Spriano (15002903)

Table S4 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents حسب Filippo Spriano (15002903)

Supplementary Data from Activation of the Unfolded Protein Response via Inhibition of Protein Disulfide Isomerase Decreases the Capacity for DNA Repair to Sensitize Glioblastoma to... حسب Yajing Liu (728964)

Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance حسب Niklas Klümper (15048887)

CCR Translation for the Article from Identification of a Novel Small Molecule HIF-1α Translation Inhibitor حسب Takuhito Narita (148955)

Data_Sheet_1_A novel music-based therapeutic approach: the Therapeutic Music Listening.PDF حسب Alfredo Raglio (16544694)

"…The paper introduces a novel approach based on music listening: the Therapeutic Music Listening. …"

Supplementary figure 1 from A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma حسب Douglas W. Sborov (10760514)

الموضوعات:

Supplementary Figures from PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma حسب Elaine Y. Chung (15011796)

Supplementary Tables from PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma حسب Elaine Y. Chung (15011796)

Table S3 from Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors حسب Laetitia Marzi (14905467)